Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intralesional bleomycin

D Dyall-Smith1

  • 1Monash Medical Centre, Clayton, Victoria, Australia.

The Australasian Journal of Dermatology
|June 5, 1998
PubMed
Summary
This summary is machine-generated.

Intralesional bleomycin effectively treated Bowen's disease on the palm in a motor mechanic. This treatment showed no recurrence or adverse effects after 18 months, offering a safe therapeutic option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five patients with melanosis of the nipple and areola clinically mimicking melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013
Same author

Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2011
Same author

Melasma of the arms associated with hormone replacement therapy.

The British journal of dermatology·1999
Same author

Melasma of the forearms.

The Australasian journal of dermatology·1997
Same author

Acrokeratoelastoidosis.

The Australasian journal of dermatology·1996
Same author

Alopecia areata in a renal transplant recipient on cyclosporin.

The Australasian journal of dermatology·1996
Same journal

Allergic Contact Dermatitis Caused by Online-Purchased Black Henna Temporary Tattoos.

The Australasian journal of dermatology·2026
Same journal

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026
Same journal

Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era.

The Australasian journal of dermatology·2026
Same journal

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series.

The Australasian journal of dermatology·2026
Same journal

The Dermatologist's Role in Early PMOS Diagnosis.

The Australasian journal of dermatology·2026
Same journal

From Curriculum Variation to Clinical Capability: Advancing Dermatology Education in Australia.

The Australasian journal of dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Bowen's disease, a form of squamous cell carcinoma in situ, can affect sun-exposed areas.
  • Treatment options for palm Bowen's disease require careful consideration due to functional demands.

Observation:

  • A motor mechanic presented with Bowen's disease on the palm.
  • Intralesional bleomycin, diluted in 1% lignocaine, was administered.

Findings:

  • Injections were given at 3-6 week intervals, with a cumulative dose of 6.35 U.
  • An 18-month follow-up revealed no local disease recurrence.
  • No long-term adverse events were reported following the treatment.

Implications:

  • Intralesional bleomycin presents a potentially safe and effective treatment for palm Bowen's disease.

Related Experiment Videos

  • This approach may be particularly relevant for patients with occupational exposures or specific anatomical locations.
  • Further studies could explore optimal dosing and long-term outcomes in larger cohorts.